Timothy Coughlin

Director, Travere Therapeutics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$1.3M

Companies

Latest trade

Jun 12, 2026

Companies

Travere Therapeutics, Inc.Director −$1.3M

Trades

TVTX Sold 10,000 shares at $50.07 · planned $0.5M Jun 12

TVTX Sold 3,250 shares at $43.49 · planned $0.1M May 15

TVTX Sold 18,000 shares at $35.03 · planned $0.6M Oct 31

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.